YHLO

YHLO focus on several priority areas such as increasing screening, prevention, and treatment for infections and chronic conditions before, during, and after pregnancy

Category

Clinical Solution

Product Overview

The reproductive system is one of the most fragile in the human body. It needs to be nurtured and protected throughout our lives. Pregnancy and fertility are prevalent factors of reproductive health. YHLO focus on several priority areas such as increasing screening, prevention, and treatment for infections and chronic conditions before, during, and after pregnancy. Currently YHLO provides a total solution of biomarkers including AMH, Inhibin B, Fertility hormones, APS, TORCH, infection screening, pregnant thyroid monitor, etc.

For women before pregnant

General reproductive health

Autoimmune disease screening

PCOS screening

IVF center

For women after pregnant

Pregnant thyroid monitor

Infectious screen

Nutrition status

Gestational diabetes

For baby and children

Infection

Sex development disorder in children

Download the IFU（German Version）：

Home

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +